September 20, 2023
RedChip Logo

RedChip Companies

Weekly Newsletter
 

BullFrog AI Announces Three-Year Global Strategic Partnership with the Lieber Institute for Brain Development

BullFrog AI (Nasdaq: BFRG), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, signed a three-year global strategic partnership with the Lieber Institute for Brain Development (LIBD), a non-profit research institute that maintains the world's largest repository of postmortem brains for the study of neuropsychiatric disorders. Under the terms of the agreement, BullFrog AI will leverage its bfLEAP™ platform to mine LIBD's comprehensive brain data, including transcriptomic, genomic, DNA methylation, cell-line, clinical, and imaging data. The goal of the partnership is to identify previously unrecognized relationships between genes and pathways in the brain and the development of neurologic and psychiatric disorders, thereby facilitating the development of more effective treatments for diseases of the human brain.

For more information, visit www.bullfrogai.com

 
See More Info
 
 
 

Splash Beverage Group Signs Letter of Intent to Acquire Western Son Vodka

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, today announced it has executed a Letter of Intent (“LOI”) to acquire JEM Beverage Management Company, LLC, owners of the brand Western Son Vodka. Western Son Vodka, founded in 2011 is headquartered in Pilot Point, Texas, with a production and distribution campus spanning more than 150,000 square feet. Over the last twelve months Western Son Vodka has sold approximately 309,000 9-liter cases of vodka. Distilled 10X and made with 100% American corn, the award-winning portfolio includes a Best-in-Class Original Vodka and is a four-time winner of Impact’s Spirits Hot Brand Award.

 
Learn More
   

BioVie Presents Data Highlighting Baseline Characteristics of Study Population in Phase 3 Trial of NE3107 in Mild to Moderate Alzheimer’s Disease

BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that preliminary baseline data from its multicenter, randomized, placebo-controlled Phase 3 study (NCT04669028) of NE3107 in patients with mild to moderate Alzheimer’s Disease (AD) was presented as a poster at the American Neurological Association (ANA) annual meeting, held September 11-13, 2023 in Philadelphia, PA.

 
Learn More
 

Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing’s Disease in Horses

Zomedica (NYSE American: ZOM), a veterinary health company offering diagnostic and therapeutic products for companion animals, announced the commercial launch of its newest assay - endogenous ACTH (eACTH) for equine plasma - for the TRUFORMA In-Clinic Biosensor Testing Platform. Larry Heaton, Zomedica's Chief Executive Officer, commented, “This assay enables equine veterinarians in the clinic or at the stall to diagnose equine Cushing's Disease, known clinically as pituitary pars intermedia dysfunction (PPID), and monitor positive patients as they titrate therapy. This new assay for the TRUFORMA instrument is an example of Zomedica's ongoing focus to meet the needs of clinical veterinarians in ways that promote both patient and practice health.”

 
Learn More
 

Genius Group Announces that ERL is Approved to List on Upstream

Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, announced that its subsidiary Entrepreneur Resorts Ltd (“ERL”) has been approved to change its listing from the main board of MERJ Exchange to Upstream, a new MERJ Exchange market. ERL will commence trading on Upstream on September 25, 2023.

 
Learn More
 

 
 

Small Stocks Big Money™ Podcasts

Available on:


 
Learn More
 
 
 

Upcoming Events

20

September

2023

NASDAQ: RVPH - Reviva Pharmaceuticals Holdings
4:15pm Eastern
Reviva is a Phase 3 clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families.
 
Sign Up
 

21

September

2023

NYSE AMERICAN: SBEV - Splash Beverage Group
4:15pm Eastern
Splash Beverage Group is constantly innovating, presenting exciting, new, natural, and healthy drinks that delight the body and inspire the mind.
 
Sign Up
 

3

October

2023

NASDAQ: RVSN - Rail Vision
11:00am Eastern
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry.
 
Sign Up
 

3

October

2023

NASDAQ: SPI - SPI Energy
4:15pm Eastern
SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California.
 
Sign Up
 

4

October

2023

NASDAQ: STSS - Sharps Technology
4:15pm Eastern
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems.
 
Sign Up
 

12

October

2023

NASDAQ: DGLY - Digital Ally
4:15pm Eastern
Digital Ally Companies is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production.
 
Sign Up
 
 
 

Archive Events

14

September

2023

NASDAQ: BFRG - BullFrog AI
Meeting Duration 43 minutes
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development.
 
Watch Replay
 

12

September

2023

NASDAQ: BIVI - BioVie
Meeting Duration 42 minutes
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease.
 
Watch Replay
 

7

September

2023

NASDAQ: ASPI - ASP Isotopes
Meeting Duration 45 minutes
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries.
 
Watch Replay
 

6

September

2023

NASDAQ: SXTP - Sixty Degrees Pharmaceuticals
Meeting Duration 35 minutes
60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases.
 
Watch Replay
 

23

August

2023

OTC: ARDS - Aridis Pharmaceuticals
Meeting Duration 37 minutes
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics.
 
Watch Replay
 

22

August

2023

NASDAQ: LTRN - Lantern Pharma
Meeting Duration 14 minutes
Lantern Pharma (NASDAQ: LTRN) is an AI company that aims to transform the cost, pace, and timeline of oncology drug discovery and development.
 
Watch Replay
 

17

August

2023

NYSE American: ZOM - Zomedica
Meeting Duration 46 minutes
Zomedica is revolutionizing veterinary health care with a focus on addressing unmet needs through its expanding product portfolio of innovative diagnostics and medical devices designed to improve pet health as well as productivity and practice profitability for veterinarians.
 
Watch Replay
 

16

August

2023

NASDAQ: GENE - Genetic Technologies Limited
Meeting Duration 41 minutes
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health.
 
Watch Replay
 

9

August

2023

NASDAQ: STSS - Sharps Technology
Meeting Duration 28 minutes
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems.
 
Watch Replay
 

26

July

2023

NYSE American: GRFX - Graphex Group
Meeting Duration 47 minutes
Graphex Group is a global leader in the mid-stream deep processing of natural spherical graphite and graphene-related products, key components of the Lithium-ion (Li-ion) batteries used in Electric Vehicles (EVs), renewable energy storage systems, and other use cases.
 
Watch Replay
 

25

July

2023

OTC: EBZT - Everything Blockchain
Meeting Duration 35 minutes
Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing.
 
Watch Replay
 

19

July

2023

NASDAQ: SNGX - Soligenix
Meeting Duration 48 minutes
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need.
 
Watch Replay
 

18

July

2023

OTCQB: QYOUF - QYOU Media
Meeting Duration 46 minutes
QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators.
 
Watch Replay
 
 
 

Lesson of the Week

Learn about value investing in this week's lesson.

 
Learn More
 
 
 
 

RedChip TV

This Week on RedChip TV: Aridis Pharmaceuticals, Genetic Technologies & American Resources Corp.

Aridis: Advancing Innovative Monoclonal Antibodies and Novel Therapies

Aridis: Advancing Innovative Monoclonal Antibodies and Novel Therapies

Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

Exclusive Interview with Genetic Technologies’ CEO Simon Morriss

Exclusive Interview with American Resources’ CEO Mark Jensen

BioVie (NASDAQ: BIVI): Poised for Significant Catalysts in 2023

ASP Isotopes: Transforming Isotope Production with State-of-the-Art Technology

Reviva: Major Breakthrough for Mental Health and Schizophrenia

An Exclusive Look at Sixty Degrees Pharma (Nasdaq: SXTP) with CEO Geoff Dow

Aridis Pharma Founder & CEO Discusses Upcoming Milestones for its Late-Stage Pipeline

Unicycive Therapeutics: Addressing a $2.5 Billion Global Market Opportunity for Kidney Diseases

ASP Isotopes: Advanced Materials Company Targeting Isotope Production

Graphex Group: Top-10 Global Producer of Graphite Anodes

Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

 
 

MidSouth Week in Review

The Dollar hit 105 vs. 99 in July. U.S. small cap stocks have hit a 22-year low relative to large caps.

 
Learn More
 

You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
© 2023 RedChip , All rights reserved